Cargando…
Studying Abnormal Chromosomal Diseases Using Patient-Derived Induced Pluripotent Stem Cells
Chromosomal abnormality causes congenital and acquired intractable diseases. In general, there are no fundamental treatments for these diseases. To establish platforms to develop therapeutics for these diseases, patient-derived induced pluripotent stem cells (iPSCs) are highly beneficial. To study a...
Autores principales: | Hayashi, Yohei, Takami, Miho, Matsuo-Takasaki, Mami |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456929/ https://www.ncbi.nlm.nih.gov/pubmed/32922264 http://dx.doi.org/10.3389/fncel.2020.00224 |
Ejemplares similares
-
Transcriptional abnormalities in induced pluripotent stem cell-derived oligodendrocytes of individuals with primary progressive multiple sclerosis
por: Plastini, Melanie J., et al.
Publicado: (2022) -
The Use of Induced Pluripotent Stem Cells as a Model for Developmental Eye Disorders
por: Eintracht, Jonathan, et al.
Publicado: (2020) -
Replacement of Mouse Microglia With Human Induced Pluripotent Stem Cell (hiPSC)-Derived Microglia in Mouse Organotypic Slice Cultures
por: Ogaki, Ari, et al.
Publicado: (2022) -
Long Term Gene Expression in Human Induced Pluripotent Stem Cells and Cerebral Organoids to Model a Neurodegenerative Disease
por: Nassor, Ferid, et al.
Publicado: (2020) -
Editorial: Pluripotent stem cell engineered 3D structures for disease modeling and tissue repairing
por: Qiang, Liang, et al.
Publicado: (2023)